spacer
spacer
Go to PDB code: 
protein links
Cytokine PDB id
1eot
Jmol
Contents
Protein chain
74 a.a. *
* Residue conservation analysis
PDB id:
1eot
Name: Cytokine
Title: Solution nmr structure of eotaxin, minimized average structure
Structure: Eotaxin. Chain: a. Engineered: yes. Other_details: both synthetic and recombinant samples were prepared. Recombinant samples were uniformly labelled with n15.
Source: Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Other_details: both synthetic and recombinant samples were prepared yes
NMR struc: 1 models
Authors: M.P.Crump,K.Rajarathnam,B.D.Sykes
Key ref:
M.P.Crump et al. (1998). Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J Biol Chem, 273, 22471-22479. PubMed id: 9712872 DOI: 10.1074/jbc.273.35.22471
Date:
17-Jun-98     Release date:   13-Jan-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P51671  (CCL11_HUMAN) -  Eotaxin
Seq:
Struc:
97 a.a.
74 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   2 terms 
  Biological process     mammary duct terminal end bud growth   22 terms 
  Biochemical function     cytokine activity     2 terms  

 

 
DOI no: 10.1074/jbc.273.35.22471 J Biol Chem 273:22471-22479 (1998)
PubMed id: 9712872  
 
 
Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.
M.P.Crump, K.Rajarathnam, K.S.Kim, I.Clark-Lewis, B.D.Sykes.
 
  ABSTRACT  
 
The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy. The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions. At pH </= 5 and low ionic strength, eotaxin was found to be predominantly a monomer. The three-dimensional structure of the eotaxin monomer solved at pH 5.0 revealed that it has a typical chemokine fold, which includes a 3-stranded beta-sheet and an overlying alpha-helix. Except for the N-terminal residues (residues 1-8), the core of the protein is well defined. The eotaxin structure is compared with the chemokines regulated upon activation, normal T-cell expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1); eotaxin binds only CC chemokine receptor CCR3, whereas RANTES binds many receptors including CCR3, and MCP-1 binds a distinct receptor, CCR2. The RMSD of the eotaxin ensemble of structures with the RANTES average minimized monomeric subunit is 5.52 +/- 0.87 A over all backbone atoms and 1.14 +/- 0.09 A over backbone atoms of residues 11-28 and 34-65. The most important difference between the structures is in the N-terminal residues that are unstructured in eotaxin but structured in RANTES and MCP-1. Several residues in the loop region of RANTES show similar packing in eotaxin (residues 11-17). As the N-terminal and loop regions have been shown to be critical for receptor binding and signaling, this structure will be useful for determining the basis for CCR3 selectivity of the eotaxin.
 
  Selected figure(s)  
 
Figure 4.
Fig. 4. Ensemble and average minimized structure of eotaxin. A, superimposition of the 32 simulated annealing structures of eotaxin on the average structure. The average structure was generated by averaging the coordinates of the 32 final eotaxin structures. The structures were overlaid on the average structure using just the backbone N, C , and C atoms of residues 9-68. B, in an orientation that optimizes clarity, the heavy atoms of well ordered side chains are labeled and superimposed on the average structure. The N and C termini are omitted for clarity. C, in the same orientation, a schematic diagram showing the restrained minimized average structure of eotaxin created with the program MOLSCRIPT (38). In this representation the helix is represented as a flat ribbon and the sheet with a broad arrow. The loops and turns are represented by a slim ribbon.
Figure 5.
Fig. 5. A, comparison of the tertiary structures of eotaxin, RANTES, and MCP-1. The minimized mean structure of one monomeric unit of both RANTES (blue, protein data base accession code 1RTO) and MCP-1 (yellow, protein data base accession code 1DOM) was used for overlaying on eotaxin (red). Backbone heavy atoms of the eotaxin minimized average structure excluding the N terminus and disulfides (residues 1-10) and the 30-s turn (residues 31-34) superimposed on MCP-1 (residues 13-32 and 37-69) with an RMSD of 1.29 Å. RANTES contains one less residue between the first -strand and the 30-s turn so eotaxin (residues 11-28 and 34-65) was superimposed on the minimized average monomeric subunit of RANTES (residues 12-29 and 34-65) giving an RMSD of 1.19 Å. B, comparison of ensembles of structures between RANTES dimer and eotaxin monomer.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (1998, 273, 22471-22479) copyright 1998.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19246006 L.S.Simpson, J.Z.Zhu, T.S.Widlanski, and M.J.Stone (2009).
Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.
  Chem Biol, 16, 153-161.  
17635911 E.L.Wise, C.Duchesnes, P.C.da Fonseca, R.A.Allen, T.J.Williams, and J.E.Pease (2007).
Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
  J Biol Chem, 282, 27935-27943.  
17291188 S.J.Allen, S.E.Crown, and T.M.Handel (2007).
Chemokine: receptor structure, interactions, and antagonism.
  Annu Rev Immunol, 25, 787-820.  
17024562 L.Rajagopalan, and K.Rajarathnam (2006).
Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.
  Biosci Rep, 26, 325-339.  
15507091 J.Elsner, S.E.Escher, and U.Forssmann (2004).
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
  Allergy, 59, 1243-1258.  
12571364 A.E.Proudfoot, T.M.Handel, Z.Johnson, E.K.Lau, P.LiWang, I.Clark-Lewis, F.Borlat, T.N.Wells, and M.H.Kosco-Vilbois (2003).
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
  Proc Natl Acad Sci U S A, 100, 1885-1890.  
12486712 K.L.Mayer, and M.J.Stone (2003).
Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines.
  Proteins, 50, 184-191.  
11807180 E.J.Fernandez, and E.Lolis (2002).
Structure, function, and inhibition of chemokines.
  Annu Rev Pharmacol Toxicol, 42, 469-499.  
11470923 B.T.Seet, R.Singh, C.Paavola, E.K.Lau, T.M.Handel, and G.McFadden (2001).
Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor.
  Proc Natl Acad Sci U S A, 98, 9008-9013.  
11276085 C.Baysal, and A.R.Atilgan (2001).
Elucidating the structural mechanisms for biological activity of the chemokine family.
  Proteins, 43, 150-160.  
11325604 T.S.Stantchev, and C.C.Broder (2001).
Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors.
  Cytokine Growth Factor Rev, 12, 219-243.  
11358512 W.Shao, E.Fernandez, A.Sachpatzidis, J.Wilken, D.A.Thompson, B.I.Schweitzer, and E.Lolis (2001).
CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure.
  Eur J Biochem, 268, 2948-2959.
PDB code: 1hhv
  11152129 Buyong, J.Xiong, J.Lubkowski, and R.Nussinov (2000).
Homology modeling and molecular dynamics simulations of lymphotactin.
  Protein Sci, 9, 2192-2199.  
11041848 E.J.Fernandez, J.Wilken, D.A.Thompson, S.C.Peiper, and E.Lolis (2000).
Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation.
  Biochemistry, 39, 12837-12844.
PDB code: 1cm9
11087354 J.Blaszczyk, E.V.Coillie, P.Proost, J.V.Damme, G.Opdenakker, G.D.Bujacz, J.M.Wang, and X.Ji (2000).
Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors.
  Biochemistry, 39, 14075-14081.
PDB code: 1esr
10913244 K.L.Mayer, and M.J.Stone (2000).
NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2.
  Biochemistry, 39, 8382-8395.
PDB codes: 1eig 1eih
10707023 N.Gerber, H.Lowman, D.R.Artis, and C.Eigenbrot (2000).
Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
  Proteins, 38, 361-367.
PDB code: 1qe6
  10595530 A.C.Liwang, Z.X.Wang, Y.Sun, S.C.Peiper, and P.J.Liwang (1999).
The solution structure of the anti-HIV chemokine vMIP-II.
  Protein Sci, 8, 2270-2280.
PDB code: 1vmp
  10379912 E.Van Coillie, J.Van Damme, and G.Opdenakker (1999).
The MCP/eotaxin subfamily of CC chemokines.
  Cytokine Growth Factor Rev, 10, 61-86.  
  10548050 M.P.Crump, L.Spyracopoulos, P.Lavigne, K.S.Kim, I.Clark-lewis, and B.D.Sykes (1999).
Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding.
  Protein Sci, 8, 2041-2054.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.